Display options
Cite
Kim H, Choi DH, Park W, et al. Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J. 2013;31(4):222-7doi: 10.3857/roj.2013.31.4.222.
Kim, H., Choi, D. H., Park, W., Huh, S. J., Nam, S. J., Lee, J. E., Ahn, J. S., & Im, Y. H. (2013). Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiation oncology journal, 31(4), 222-7. https://doi.org/10.3857/roj.2013.31.4.222
Kim, Haeyoung, et al. "Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients." Radiation oncology journal vol. 31,4 (2013): 222-7. doi: https://doi.org/10.3857/roj.2013.31.4.222
Kim H, Choi DH, Park W, Huh SJ, Nam SJ, Lee JE, Ahn JS, Im YH. Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J. 2013 Dec;31(4):222-7. doi: 10.3857/roj.2013.31.4.222. Epub 2013 Dec 31. PMID: 24501710; PMCID: PMC3912236.
Copy Download .nbib Format: NLM
Share it on

Radiat Oncol J. 2013 Dec;31(4):222-7. doi: 10.3857/roj.2013.31.4.222. Epub 2013 Dec 31.

Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients.

Radiation oncology journal

Haeyoung Kim, Doo Ho Choi, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Jin Seok Ahn, Young-Hyuck Im

Affiliations

  1. Department of Radiation Oncology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
  2. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  3. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  4. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 24501710 PMCID: PMC3912236 DOI: 10.3857/roj.2013.31.4.222

Abstract

PURPOSE: This study was performed to evaluate prognostic factors for survival from first relapse (SFFR) in stage I-III breast cancer patients.

MATERIALS AND METHODS: From June 1994 to June 2008, 3,835 patients were treated with surgery plus postoperative radiotherapy and adjuvant chemotherapy for stage I-III breast cancer at Samsung Medical Center. Among them, a total of 224 patients died by June 2009, and 175 deaths were of breast cancer. Retrospective review was performed on medical records of 165 patients who met the inclusion criteria of this study. Univariate and multivariate analysis were done on survivals according to variables, such as age, stage, hormone status of tumor, disease-free interval (DFI), sites of first failure, number of organs involved by recurrent disease (NOR), application of salvage treatments, and existence of brain or liver metastasis (visceral metastasis).

RESULTS: Patients' median overall survival time was 38 months (range, 8 to 123 months). Median SFFR was 17 months (range, 5 to 87 months). Ninety percent of deaths occurred within 40 months after first recurrence. The patients with SFFR ≤1 year had tendency of triple-negativity, shorter DFI (≤2 years), larger NOR (>3), visceral metastasis for first relapse than the patients with SFFR >1 year. In multivariate analysis, longer DFI (>2 vs. ≤2 years), absence of visceral metastasis, and application of salvage treatments were statistically significant prognosticators for longer SFFR.

CONCLUSION: The DFI, application of salvage treatments, and visceral metastasis were significant prognostic factors for SFFR in breast cancer patients.

Keywords: Breast neoplasms; Prognosis; Recurrence; Survival

References

  1. BMJ. 2003 Jan 4;326(7379):29 - PubMed
  2. J Natl Cancer Inst. 2008 Dec 17;100(24):1780-91 - PubMed
  3. J Clin Oncol. 2001 Feb 15;19(4):980-91 - PubMed
  4. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34 - PubMed
  5. Support Care Cancer. 1999 May;7(3):128-33 - PubMed
  6. Cancer. 2003 Feb 1;97(3):545-53 - PubMed
  7. Cancer. 1992 Jul 1;70(1):129-35 - PubMed
  8. J Clin Oncol. 2008 Mar 10;26(8):1275-81 - PubMed
  9. Breast Cancer Res Treat. 1992;22(3):221-7 - PubMed
  10. Cancer. 2007 Sep 1;110(5):973-9 - PubMed
  11. Oncol Rep. 2001 Jul-Aug;8(4):795-800 - PubMed
  12. BMC Cancer. 2011 Mar 31;11:118 - PubMed
  13. Breast Cancer Res Treat. 2011 Aug;128(3):827-35 - PubMed
  14. J Clin Oncol. 1987 Jan;5(1):55-61 - PubMed
  15. Cancer. 1986 Mar 1;57(5):925-8 - PubMed
  16. Breast Cancer Res Treat. 2010 Jul;122(2):591-600 - PubMed
  17. Breast. 2010 Oct;19(5):312-21 - PubMed
  18. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  19. J Pain Symptom Manage. 1992 Feb;7(2):82-6 - PubMed
  20. J Pain Symptom Manage. 2004 Aug;28(2):115-22 - PubMed
  21. J Pain Symptom Manage. 1999 Apr;17(4):231-9 - PubMed

Publication Types